# Ravi Thadhani

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ravi-thadhani/

## Facts

| Field | Value |
| --- | --- |
| Citations | 44,044 |
| Field | Pregnancy and preeclampsia studies |
| h-index | 102 |
| i10-index | 280 |
| Last Known Institution | Emory Healthcare |
| OpenAlex ID | https://openalex.org/A5041339585 |
| ORCID iD | https://orcid.org/0000-0001-8315-9938 |
| Works | 414 |

## Researcher papers

- [Circulating Angiogenic Factors and the Risk of Preeclampsia](https://scholariq.org/papers/circulating-angiogenic-factors-and-the-risk-of-preeclampsia/)
- [Pre-eclampsia: pathogenesis, novel diagnostics and therapies](https://scholariq.org/papers/pre-eclampsia-pathogenesis-novel-diagnostics-and-therapies/)
- [Vitamin D–Binding Protein and Vitamin D Status of Black Americans and White Americans](https://scholariq.org/papers/vitamin-d-binding-protein-and-vitamin-d-status-of-black-americans-and-white/)
- [Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol Therapy](https://scholariq.org/papers/survival-of-patients-undergoing-hemodialysis-with-paricalcitol-or-calcitriol/)
- [Prevalence of Cardiovascular Risk Factors and the Serum Levels of 25-Hydroxyvitamin D in the United States](https://scholariq.org/papers/prevalence-of-cardiovascular-risk-factors-and-the-serum-levels-of-25/)
- [Activated Injectable Vitamin D and Hemodialysis Survival](https://scholariq.org/papers/activated-injectable-vitamin-d-and-hemodialysis-survival/)
- [Warfarin Use Associates with Increased Risk for Stroke in Hemodialysis Patients with Atrial Fibrillation](https://scholariq.org/papers/warfarin-use-associates-with-increased-risk-for-stroke-in-hemodialysis-patients/)
- [Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia](https://scholariq.org/papers/pilot-study-of-extracorporeal-removal-of-soluble-fms-like-tyrosine-kinase-1-in/)
- [Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis](https://scholariq.org/papers/dabigatran-and-rivaroxaban-use-in-atrial-fibrillation-patients-on-hemodialysis/)
- [Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia](https://scholariq.org/papers/removal-of-soluble-fms-like-tyrosine-kinase-1-by-dextran-sulfate-apheresis-in/)
- [Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial](https://scholariq.org/papers/apixaban-for-patients-with-atrial-fibrillation-on-hemodialysis-a-multicenter/)
- [Early Outcomes among Those Initiating Chronic Dialysis in the United States](https://scholariq.org/papers/early-outcomes-among-those-initiating-chronic-dialysis-in-the-united-states/)

## Researcher topics

- [Pregnancy and preeclampsia studies](https://scholariq.org/topics/pregnancy-and-preeclampsia-studies/)
- [Vitamin D Research Studies](https://scholariq.org/topics/vitamin-d-research-studies-2/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Birth, Development, and Health](https://scholariq.org/topics/birth-development-and-health/)

## Researcher university

- [Emory Healthcare](https://scholariq.org/institutions/emory-healthcare/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.